United Therapeutics (UTHR) has opened its third designated pathogen-free xenograft production facility in Houston, Texas, the company said Tuesday.
The new facility and the second facility in Minnesota, which was opened in August, are intended to help the company scale commercial production of its xeno-organs following their approval, according to the statement.
United Therapeutics said its xeno-organs remain investigational-stage products.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments